Jens Meiler Archives
Poster session Friday will feature work on next-gen vaccines
Aug. 6, 2018—The computer-aided design and engineering of antibodies and vaccine candidates that can neutralize viral scourges like influenza and Ebola will be the topic of an Aug. 17 poster session presented by the Vanderbilt Center for Structural Biology and the Vanderbilt Vaccine Center.
Characterizing ‘keyhole’ is first step to fighting obesity at the cellular level
Apr. 18, 2018—A Vanderbilt team and their international colleagues characterized for the first time a complex, little-understood cellular receptor type that, when activated, shuts off hunger.
New working group to assess and prioritize opportunities for enhancing research IT resources on campus
Mar. 17, 2017—The Research IT Special Project Working Group will advance the efforts of the Provost’s Initiative to Enhance Research and Scholarship, or PIERS.
Transcription factor evolution
Aug. 11, 2016—Vanderbilt researchers have discovered a novel model of evolution for factors that control gene expression.
‘Young Scientist’ showcases high schoolers’ research at Vanderbilt
Jun. 2, 2016—High school students performing advanced research at Vanderbilt have the opportunity to share their findings with the scientific community through a journal of their own.
Potent HIV antibodies suggest new vaccine development approach
Apr. 7, 2016—It’s been known for some time that the immune system can produce antibodies capable of “neutralizing” HIV, and stopping the AIDS-causing virus dead in its tracks.
Dynamics of a drug resistance transporter
Feb. 5, 2016—Vanderbilt investigators are exploring the shape changes in a multidrug transporter to understand the mechanisms of antibacterial resistance.
Chemist Jens Meiler receives Humboldt Foundation award
Dec. 15, 2015—Associate Professor of Chemistry Jens Meiler has received a Friedrich Wilhelm Bessel Research Award from the Alexander von Humboldt Foundation in Bonn, Germany.
‘Redesigned’ antibodies may control HIV: study
May. 21, 2015—With the help of a computer program called “Rosetta,” researchers at Vanderbilt University have “redesigned” an antibody that has increased potency and can neutralize more strains of the AIDS-causing human immunodeficiency virus (HIV) than can any known natural antibody.
VU lands $9 million NIH grant to design better flu vaccines
May. 15, 2015—Vanderbilt University researchers have received a five-year, $9 million grant from the National Institutes of Health (NIH) to design more effective flu vaccines and novel antibody therapies.
Members named to Academic Strategic Plan committees
Oct. 27, 2014—Two committees tasked with fleshing out key initiatives in Vanderbilt’s Academic Strategic Plan are now staffed and ready to begin work.
New undergraduate and faculty research collaborations inspire, inform
Apr. 29, 2014—The Littlejohn Family Undergraduate Research Program enables Arts and Science undergraduates to conduct original research alongside faculty fellows.